{"entity":{"type":"insider","cik":"0001253170","url":"/insider/0001253170","json_url":"/insider/0001253170.json","name":"AKKARAJU SRINIVAS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":227,"n_filings":92,"first":"2004-06-04","last":"2026-05-22","span_basis":"filed_date"},"name_variants":[{"name":"AKKARAJU SRINIVAS","source":"filing","n_filings":92,"first_seen":"2004-06-04","last_seen":"2026-05-22"}],"transactions":[{"id":5752533,"accession":"0001231919-26-000532","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001231919-26-000532","line_url":"/filing/0001231919-26-000532#line-4","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Kalaris Therapeutics, Inc.","issuer_ticker":"KLRS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC; Samsara Opportunity Fund GP, LLC; Samsara Opportunity Fund, L.P.","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":244300.0,"shares_display":"244,300","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":1179969.0,"total_display":"1,179,969.00","total_whole":"1,179,969","shares_owned_after":2224147.0,"shares_owned_after_display":"2,224,147","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-22","scope":"insider"},{"id":5945604,"accession":"0001253170-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253170-26-000004","line_url":"/filing/0001253170-26-000004#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":588235.0,"shares_display":"588,235","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":9999995.0,"total_display":"9,999,995.00","total_whole":"9,999,995","shares_owned_after":1853488.0,"shares_owned_after_display":"1,853,488","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider"},{"id":5799467,"accession":"0001231919-26-000166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000166","line_url":"/filing/0001231919-26-000166#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Kalaris Therapeutics, Inc.","issuer_ticker":"KLRS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara Opportunity Fund GP, LLC; Samsara BioCapital, L.P.; Samsara Opportunity Fund, L.P.; Samsara BioCapital GP, LLC","owner_display_name":"Samsara Opportunity Fund GP, LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":479847.0,"shares_display":"479,847","price_per_share":10.42,"price_display":"10.42","price_state":"stated","total_value":5000005.74,"total_display":"5,000,005.74","total_whole":"5,000,006","shares_owned_after":1979847.0,"shares_owned_after_display":"1,979,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-18","filed_date":"2026-02-17","scope":"insider"},{"id":4680930,"accession":"0001253170-25-000021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001253170-25-000021","line_url":"/filing/0001253170-25-000021","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":186377.0,"shares_display":"186,377","price_per_share":9.838983511914023,"price_display":"9.84","price_state":"stated","total_value":1833760.23,"total_display":"1,833,760.23","total_whole":"1,833,760","shares_owned_after":1213873.0,"shares_owned_after_display":"1,213,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-05","filed_date":"2025-12-09","scope":"insider","n_lines":3},{"id":4049539,"accession":"0001253170-25-000019","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001253170-25-000019","line_url":"/filing/0001253170-25-000019#line-3","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66027.0,"shares_display":"66,027","price_per_share":8.18,"price_display":"8.18","price_state":"stated","total_value":540100.86,"total_display":"540,100.86","total_whole":"540,101","shares_owned_after":1078876.0,"shares_owned_after_display":"1,078,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-04","scope":"insider"},{"id":4049538,"accession":"0001253170-25-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001253170-25-000019","line_url":"/filing/0001253170-25-000019#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":775000.0,"total_display":"775,000.00","total_whole":"775,000","shares_owned_after":1012849.0,"shares_owned_after_display":"1,012,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-04","scope":"insider"},{"id":4049537,"accession":"0001253170-25-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253170-25-000019","line_url":"/filing/0001253170-25-000019#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":96000.0,"shares_display":"96,000","price_per_share":7.55,"price_display":"7.55","price_state":"stated","total_value":724800.0,"total_display":"724,800.00","total_whole":"724,800","shares_owned_after":912849.0,"shares_owned_after_display":"912,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-02","filed_date":"2025-12-04","scope":"insider"},{"id":4459435,"accession":"0001253170-25-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001253170-25-000017","line_url":"/filing/0001253170-25-000017#line-3","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86350.0,"shares_display":"86,350","price_per_share":7.46,"price_display":"7.46","price_state":"stated","total_value":644171.0,"total_display":"644,171.00","total_whole":"644,171","shares_owned_after":816849.0,"shares_owned_after_display":"816,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-01","scope":"insider"},{"id":4459430,"accession":"0001253170-25-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001253170-25-000017","line_url":"/filing/0001253170-25-000017#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38702.0,"shares_display":"38,702","price_per_share":7.64,"price_display":"7.64","price_state":"stated","total_value":295683.28,"total_display":"295,683.28","total_whole":"295,683","shares_owned_after":730499.0,"shares_owned_after_display":"730,499","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-28","filed_date":"2025-12-01","scope":"insider"},{"id":4459424,"accession":"0001253170-25-000017","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253170-25-000017","line_url":"/filing/0001253170-25-000017#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48537.0,"shares_display":"48,537","price_per_share":7.64,"price_display":"7.64","price_state":"stated","total_value":370822.68,"total_display":"370,822.68","total_whole":"370,823","shares_owned_after":691797.0,"shares_owned_after_display":"691,797","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-12-01","scope":"insider"},{"id":5072436,"accession":"0001253170-25-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253170-25-000014","line_url":"/filing/0001253170-25-000014#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125743.0,"shares_display":"125,743","price_per_share":7.2,"price_display":"7.20","price_state":"stated","total_value":905349.6,"total_display":"905,349.60","total_whole":"905,350","shares_owned_after":643260.0,"shares_owned_after_display":"643,260","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-20","filed_date":"2025-11-24","scope":"insider"},{"id":5000651,"accession":"0001253170-25-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001253170-25-000011","line_url":"/filing/0001253170-25-000011#line-3","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":137772.0,"shares_display":"137,772","price_per_share":6.56,"price_display":"6.56","price_state":"stated","total_value":903784.32,"total_display":"903,784.32","total_whole":"903,784","shares_owned_after":517517.0,"shares_owned_after_display":"517,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-19","filed_date":"2025-11-19","scope":"insider"},{"id":5000646,"accession":"0001253170-25-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001253170-25-000011","line_url":"/filing/0001253170-25-000011#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":102652.0,"shares_display":"102,652","price_per_share":6.05,"price_display":"6.05","price_state":"stated","total_value":621044.6,"total_display":"621,044.60","total_whole":"621,045","shares_owned_after":379745.0,"shares_owned_after_display":"379,745","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-18","filed_date":"2025-11-19","scope":"insider"},{"id":5000642,"accession":"0001253170-25-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253170-25-000011","line_url":"/filing/0001253170-25-000011#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":914.0,"shares_display":"914","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":5036.14,"total_display":"5,036.14","total_whole":"5,036","shares_owned_after":277093.0,"shares_owned_after_display":"277,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-19","scope":"insider"},{"id":4049536,"accession":"0001253170-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001253170-25-000008","line_url":"/filing/0001253170-25-000008#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":276179.0,"shares_display":"276,179","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":1449939.75,"total_display":"1,449,939.75","total_whole":"1,449,940","shares_owned_after":276179.0,"shares_owned_after_display":"276,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-17","scope":"insider"},{"id":4034528,"accession":"0001253170-25-000025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001253170-25-000025","line_url":"/filing/0001253170-25-000025","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29599.0,"shares_display":"29,599","price_per_share":39.92140511503767,"price_display":"39.92","price_state":"stated","total_value":1181633.67,"total_display":"1,181,633.67","total_whole":"1,181,634","shares_owned_after":513235.0,"shares_owned_after_display":"513,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-12-16","scope":"insider","n_lines":3},{"id":4680920,"accession":"0001253170-25-000006","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001253170-25-000006","line_url":"/filing/0001253170-25-000006","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":113025.0,"shares_display":"113,025","price_per_share":38.653468347710685,"price_display":"38.65","price_state":"stated","total_value":4368808.26,"total_display":"4,368,808.26","total_whole":"4,368,808","shares_owned_after":486691.0,"shares_owned_after_display":"486,691","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-07","scope":"insider","n_lines":3},{"id":4680909,"accession":"0001253170-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001253170-25-000006","line_url":"/filing/0001253170-25-000006","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":387414.0,"shares_display":"387,414","price_per_share":37.269029849205246,"price_display":"37.27","price_state":"stated","total_value":14438543.93,"total_display":"14,438,543.93","total_whole":"14,438,544","shares_owned_after":387414.0,"shares_owned_after_display":"387,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-03","filed_date":"2025-10-07","scope":"insider","n_lines":3},{"id":4642159,"accession":"0001415889-25-023919","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023919","line_url":"/filing/0001415889-25-023919#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":588235.0,"shares_display":"588,235","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":14999992.5,"total_display":"14,999,992.50","total_whole":"14,999,993","shares_owned_after":588235.0,"shares_owned_after_display":"588,235","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-04","filed_date":"2025-09-08","scope":"insider"},{"id":4589600,"accession":"0001415889-25-012166","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-012166","line_url":"/filing/0001415889-25-012166","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":160370.0,"shares_display":"160,370","price_per_share":4.674664712851531,"price_display":"4.67","price_state":"stated","total_value":749675.98,"total_display":"749,675.98","total_whole":"749,676","shares_owned_after":3564786.0,"shares_owned_after_display":"3,564,786","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-05","filed_date":"2025-05-06","scope":"insider","n_lines":2},{"id":4589592,"accession":"0001415889-25-012166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-012166","line_url":"/filing/0001415889-25-012166#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":159920.0,"shares_display":"159,920","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":727636.0,"total_display":"727,636.00","total_whole":"727,636","shares_owned_after":3426418.0,"shares_owned_after_display":"3,426,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-02","filed_date":"2025-05-06","scope":"insider"},{"id":4885661,"accession":"0001415889-25-008274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008274","line_url":"/filing/0001415889-25-008274#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600000.0,"shares_display":"600,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":8100000.0,"total_display":"8,100,000.00","total_whole":"8,100,000","shares_owned_after":5674916.0,"shares_owned_after_display":"5,674,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-13","filed_date":"2025-03-17","scope":"insider"},{"id":2449711,"accession":"0001415889-24-027861","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-027861","line_url":"/filing/0001415889-24-027861","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Neurogene Inc.","issuer_ticker":"NGNE","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48770.0,"shares_display":"48,770","price_per_share":25.827815870412138,"price_display":"25.83","price_state":"stated","total_value":1259622.58,"total_display":"1,259,622.58","total_whole":"1,259,623","shares_owned_after":1689105.0,"shares_owned_after_display":"1,689,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-26","filed_date":"2024-11-27","scope":"insider","n_lines":4},{"id":2864022,"accession":"0001415889-24-024852","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-024852","line_url":"/filing/0001415889-24-024852","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1175713.0,"shares_display":"1,175,713","price_per_share":29.24665500849272,"price_display":"29.25","price_state":"stated","total_value":34385672.5,"total_display":"34,385,672.50","total_whole":"34,385,673","shares_owned_after":5768609.0,"shares_owned_after_display":"5,768,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-07","filed_date":"2024-10-07","scope":"insider","n_lines":3},{"id":9287295,"accession":"0001415889-24-022292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-022292","line_url":"/filing/0001415889-24-022292#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"ALUMIS INC.","issuer_ticker":"ALMS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1562500.0,"shares_display":"1,562,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":25000000.0,"total_display":"25,000,000.00","total_whole":"25,000,000","shares_owned_after":3266498.0,"shares_owned_after_display":"3,266,498","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-08-27","scope":"insider"},{"id":2330007,"accession":"0001415889-24-015250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015250","line_url":"/filing/0001415889-24-015250#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"CARGO Therapeutics, Inc.","issuer_ticker":"CRGX","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":294000.0,"shares_display":"294,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":4998000.0,"total_display":"4,998,000.00","total_whole":"4,998,000","shares_owned_after":4415689.0,"shares_owned_after_display":"4,415,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-06-03","scope":"insider"},{"id":7974271,"accession":"0001209191-23-059693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059693","line_url":"/filing/0001209191-23-059693#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Syros Pharmaceuticals, Inc.","issuer_ticker":"SYRS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":904977.0,"shares_display":"904,977","price_per_share":4.42,"price_display":"4.42","price_state":"stated","total_value":3999998.34,"total_display":"3,999,998.34","total_whole":"3,999,998","shares_owned_after":1786427.0,"shares_owned_after_display":"1,786,427","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider"},{"id":8255533,"accession":"0001209191-23-055621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-055621","line_url":"/filing/0001209191-23-055621#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"CARGO Therapeutics, Inc.","issuer_ticker":"CRGX","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"AKKARAJU SRINIVAS; Samsara BioCapital, L.P.; Samsara BioCapital GP, LLC","owner_display_name":"AKKARAJU SRINIVAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":4121689.0,"shares_owned_after_display":"4,121,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":8727060,"accession":"0001209191-23-053113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053113","line_url":"/filing/0001209191-23-053113#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2189781.0,"shares_display":"2,189,781","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":14999999.85,"total_display":"14,999,999.85","total_whole":"15,000,000","shares_owned_after":6788609.0,"shares_owned_after_display":"6,788,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-16","filed_date":"2023-10-18","scope":"insider"},{"id":8268226,"accession":"0001628280-23-003923","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-003923","line_url":"/filing/0001628280-23-003923#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"AKKARAJU SRINIVAS; Samsara BioCapital, L.P.","owner_display_name":"AKKARAJU SRINIVAS","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":937500.0,"shares_display":"937,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":4519361.0,"shares_owned_after_display":"4,519,361","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-16","scope":"insider"},{"id":6276092,"accession":"0001209191-22-033141","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-033141","line_url":"/filing/0001209191-22-033141#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":"0001253170","owner_name":"AKKARAJU SRINIVAS","owner_display_name":"AKKARAJU SRINIVAS","owner_url":"/insider/0001253170","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":570000.0,"shares_display":"570,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7980000.0,"total_display":"7,980,000.00","total_whole":"7,980,000","shares_owned_after":5161888.0,"shares_owned_after_display":"5,161,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-06-01","scope":"insider"},{"id":6652930,"accession":"0001209191-22-024364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-024364","line_url":"/filing/0001209191-22-024364#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Graphite Bio, Inc.","issuer_ticker":"GRPH","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"AKKARAJU SRINIVAS; Samsara BioCapital, L.P.","owner_display_name":"AKKARAJU SRINIVAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":4.08,"price_display":"4.08","price_state":"stated","total_value":1428000.0,"total_display":"1,428,000.00","total_whole":"1,428,000","shares_owned_after":8459314.0,"shares_owned_after_display":"8,459,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-13","scope":"insider"},{"id":6652926,"accession":"0001209191-22-024364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-024364","line_url":"/filing/0001209191-22-024364#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Graphite Bio, Inc.","issuer_ticker":"GRPH","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"AKKARAJU SRINIVAS; Samsara BioCapital, L.P.","owner_display_name":"AKKARAJU SRINIVAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74464.0,"shares_display":"74,464","price_per_share":4.07,"price_display":"4.07","price_state":"stated","total_value":303068.48,"total_display":"303,068.48","total_whole":"303,068","shares_owned_after":8109314.0,"shares_owned_after_display":"8,109,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider"},{"id":6446752,"accession":"0001209191-22-004735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-004735","line_url":"/filing/0001209191-22-004735#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Graphite Bio, Inc.","issuer_ticker":"GRPH","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23000.0,"shares_display":"23,000","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":200100.0,"total_display":"200,100.00","total_whole":"200,100","shares_owned_after":8034850.0,"shares_owned_after_display":"8,034,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":6446749,"accession":"0001209191-22-004735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-004735","line_url":"/filing/0001209191-22-004735#line-1","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Graphite Bio, Inc.","issuer_ticker":"GRPH","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":8.99,"price_display":"8.99","price_state":"stated","total_value":899000.0,"total_display":"899,000.00","total_whole":"899,000","shares_owned_after":8011850.0,"shares_owned_after_display":"8,011,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-21","filed_date":"2022-01-25","scope":"insider"},{"id":6722306,"accession":"0001209191-22-004346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-004346","line_url":"/filing/0001209191-22-004346#line-2","is_derivative":false,"issuer_cik":"0001253170","issuer_name":"Graphite Bio, Inc.","issuer_ticker":"GRPH","issuer_name_source":null,"issuer_url":"/issuer/0001253170","owner_cik":null,"owner_name":"Samsara BioCapital, L.P.; AKKARAJU SRINIVAS","owner_display_name":"Samsara BioCapital, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43105.0,"shares_display":"43,105","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":384496.6,"total_display":"384,496.60","total_whole":"384,497","shares_owned_after":7911850.0,"shares_owned_after_display":"7,911,850","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-20","filed_date":"2022-01-21","scope":"insider"}],"collapsed":true,"next_cursor":"2022-01-20|6722306","ledger_fault":false,"count":{"value":188,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":68,"open_market":true},{"code":"S","label":"Open-market sale","n":120,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":188},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001754068","name":"Kalaris Therapeutics, Inc.","url":"/issuer/0001754068","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2026-02-17","last_seen":"2026-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001847367","name":"ALUMIS INC.","url":"/issuer/0001847367","role":"Director","n_filings":9,"first_seen":"2024-08-27","last_seen":"2026-01-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001727196","name":"Scholar Rock Holding Corp","url":"/issuer/0001727196","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2023-10-18","last_seen":"2025-12-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2023-02-16","last_seen":"2025-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001404644","name":"Neurogene Inc.","url":"/issuer/0001404644","role":"Ten percent owner","n_filings":1,"first_seen":"2024-11-27","last_seen":"2024-11-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001966494","name":"CARGO Therapeutics, Inc.","url":"/issuer/0001966494","role":"Ten percent owner","n_filings":2,"first_seen":"2023-11-16","last_seen":"2024-06-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Director","n_filings":7,"first_seen":"2017-12-14","last_seen":"2023-12-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"CHINOOK THERAPEUTICS, INC.","url":"/issuer/0001435049","role":"Director","n_filings":3,"first_seen":"2021-08-20","last_seen":"2022-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001815776","name":"Graphite Bio, Inc.","url":"/issuer/0001815776","role":"Ten percent owner","n_filings":8,"first_seen":"2021-07-01","last_seen":"2022-04-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS, INC.","url":"/issuer/0001270073","role":"Director","n_filings":8,"first_seen":"2012-10-16","last_seen":"2021-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001060736","name":"SEATTLE GENETICS INC /WA","url":"/issuer/0001060736","role":"Director","n_filings":20,"first_seen":"2007-02-14","last_seen":"2020-05-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001513818","name":"Aravive, Inc.","url":"/issuer/0001513818","role":"Director, Ten percent owner","n_filings":7,"first_seen":"2014-03-28","last_seen":"2019-12-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Director","n_filings":1,"first_seen":"2018-09-20","last_seen":"2018-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001557746","name":"Aclaris Therapeutics, Inc.","url":"/issuer/0001557746","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-13","last_seen":"2015-10-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001527599","name":"Mirna Therapeutics, Inc.","url":"/issuer/0001527599","role":"Ten percent owner","n_filings":1,"first_seen":"2015-10-06","last_seen":"2015-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Director, Other","n_filings":1,"first_seen":"2015-05-14","last_seen":"2015-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001372299","name":"HISTOGENICS CORP","url":"/issuer/0001372299","role":"Ten percent owner","n_filings":1,"first_seen":"2014-12-10","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001262104","name":"MEI Pharma, Inc.","url":"/issuer/0001262104","role":"Ten percent owner","n_filings":1,"first_seen":"2013-02-20","last_seen":"2013-02-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Ten percent owner","n_filings":1,"first_seen":"2012-07-26","last_seen":"2012-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0000911326","name":"SYNAGEVA BIOPHARMA CORP","url":"/issuer/0000911326","role":"Director, Other","n_filings":2,"first_seen":"2012-03-21","last_seen":"2012-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001178711","name":"Transcept Pharmaceuticals Inc","url":"/issuer/0001178711","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2011-07-15","last_seen":"2011-07-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001024520","name":"WORLD HEART CORP","url":"/issuer/0001024520","role":"Ten percent owner","n_filings":2,"first_seen":"2010-01-28","last_seen":"2010-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001173657","name":"BARRIER THERAPEUTICS INC","url":"/issuer/0001173657","role":"Director","n_filings":3,"first_seen":"2005-01-04","last_seen":"2007-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001115285","name":"EYETECH PHARMACEUTICALS INC","url":"/issuer/0001115285","role":"Director","n_filings":2,"first_seen":"2004-06-04","last_seen":"2004-10-29"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001253170","retrieved_at":"2026-08-23T23:08:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}